HESS BRIAN 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Oct 31, 2012
Insider Transaction Report
Form 4
HESS BRIAN
CHIEF SCIENCE OFFICER
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2012-10-26+200,000→ 200,000 totalExercise: $1.69Exp: 2022-10-25→ COMMON STOCK (200,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in equal monthly installments.